Cargando…
Minimizing second cancer risk following radiotherapy: current perspectives
Secondary cancer risk following radiotherapy is an increasingly important topic in clinical oncology with impact on treatment decision making and on patient management. Much of the evidence that underlies our understanding of secondary cancer risks and our risk estimates are derived from large epide...
Autores principales: | Ng, John, Shuryak, Igor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274043/ https://www.ncbi.nlm.nih.gov/pubmed/25565886 http://dx.doi.org/10.2147/CMAR.S47220 |
Ejemplares similares
-
Lung Cancer and Heart Disease Risks Associated With Low-Dose Pulmonary Radiotherapy to COVID-19 Patients With Different Background Risks
por: Shuryak, Igor, et al.
Publicado: (2021) -
Second Malignant Neoplasms Following Radiotherapy
por: Kumar, Sanath
Publicado: (2012) -
Future Perspectives of Proton Therapy in Minimizing the Toxicity of Breast Cancer Radiotherapy
por: Musielak, Marika, et al.
Publicado: (2021) -
Potential Reduction of Contralateral Second Breast-Cancer Risks by Prophylactic Mammary Irradiation: Validation in a Breast-Cancer-Prone Mouse Model
por: Shuryak, Igor, et al.
Publicado: (2013) -
A new view of radiation-induced cancer: integrating short- and long-term processes. Part II: second cancer risk estimation
por: Shuryak, Igor, et al.
Publicado: (2009)